Rezpegaldesleukin (NKTR-358)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rezpegaldesleukin (NKTR-358), covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus [Phase 2]